Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy

  • Jessica Pahle1,
  • Lutz Menzel2,
  • Nicole Niesler2,
  • Dennis Kobelt2,
  • Jutta Aumann1,
  • Maria Rivera3 and
  • Wolfgang Walther1, 2Email author
BMC Cancer201717:129

https://doi.org/10.1186/s12885-017-3123-x

Received: 23 September 2015

Accepted: 8 February 2017

Published: 13 February 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 Sep 2015 Submitted Original manuscript
21 Jan 2016 Reviewed Reviewer Report - Guy Berchem
11 May 2016 Reviewed Reviewer Report - Darren Browning
3 Jun 2016 Author responded Author comments - Jessica Pahle
Resubmission - Version 2
3 Jun 2016 Submitted Manuscript version 2
23 Jun 2016 Reviewed Reviewer Report - Darren Browning
7 Oct 2016 Author responded Author comments - Jessica Pahle
Resubmission - Version 3
7 Oct 2016 Submitted Manuscript version 3
23 Jan 2017 Author responded Author comments - Jessica Pahle
Resubmission - Version 4
23 Jan 2017 Submitted Manuscript version 4
31 Jan 2017 Author responded Author comments - Jessica Pahle
Resubmission - Version 5
31 Jan 2017 Submitted Manuscript version 5
Publishing
8 Feb 2017 Editorially accepted
13 Feb 2017 Article published 10.1186/s12885-017-3123-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Experimental and Clinical Research Center, Charité University Medicine
(2)
Max-Delbrück-Center for Molecular Medicine
(3)
Experimental Pharmacology & Oncology (EPO) GmbH Berlin

Advertisement